Firm-Wide

The FDA Has Issued Increased Warnings for Depakote Use During Pregnancy

The FDA Has Issued Increased Warnings for Depakote Use During Pregnancy

By Burg Simpson
May 6, 2013
1 min read

“The FDA released a MedWatch safety alert today to increase the warnings for valproate products, such as Depakote® (divalproex sodium), Depacon® (valproate sodium), Depakene® (valproic acid), Stavzor® (valproic acid), and their generics. Valproate products are approved for the treatment of epilepsy, manic episodes associated with bipolar disorder, and prevention of migraine headaches. However, today the FDA warned…”

Free case evaluation form